Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,543,314,200    

Indirect Value

   $7,622,100,274      
Total Shares   186,710,189      
Total Value   $10,165,414,474      


Neurocrine Biosciences Inc $708,575,376 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,035,632 Ligand Pharmaceuticals Inc $1,319,785,650 Curis Inc $3,390,252 Repligen Corp $461,473,020 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $708,575,376 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,035,632 Ligand Pharmaceuticals Inc $1,319,785,650 Curis Inc $3,390,252 Repligen Corp $461,473,020 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 8 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGXP Sgx Pharmaceuticals, Inc. Indirect Beneficial Owner   –       –       •   2008-07-09 4 B $3.04 $2,434,112 I/I 800,300 5,091,974 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-09-22 4 S $8.72 $2,468,768 I/I (283,200) 4,383,115 0 -
RGEN Repligen Corp Indirect Beneficial Owner   –       –       •   2009-07-06 4 S $5.52 $2,486,478 D/D (450,800) 2,766,050 0 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2006-01-12 4 S $15.69 $2,491,704 I/I (158,700) 1,116,433 -
EPRS Epirus Biopharmaceuticals... Direct Beneficial Owner   –       –       •   2009-12-22 4 S $0.80 $2,542,319 D/D (3,177,899) 6,830,972 0 -
AMAG AMAG Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2005-08-11 4 S $11.92 $2,553,639 I/I (213,800) 1,224,533 -
DVAX Dynavax Technologies Corp Indirect Beneficial Owner   –       –       •   2009-06-03 4 S $1.99 $2,565,654 D/D (1,292,000) 6,818,657 0 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-26 4 B $1.93 $2,622,922 I/I 1,350,000 12,819,653 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $2.35 $3,145,475 I/I 1,338,500 10,819,560 1.5 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-09-10 4 S $2.76 $3,350,988 D/D (1,212,106) 4,278,851 0 -
CRIS Curis Inc Indirect Beneficial Owner   –       –       •   2009-04-27 4 S $1.15 $3,415,500 I/I (2,970,000) 5,951,716 0 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-28 4 B $2.75 $3,738,985 I/I 1,351,119 6,125,651 1.5 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2004-07-07 4 S $5.10 $3,885,176 I/I (761,288) 1,026,851 -
NTII Neurobiological Technolog... Direct Beneficial Owner   –       –       •   2009-10-21 4 S $0.91 $4,191,819 D/D (4,606,395) 331,998 0 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-03-10 4 B $3.90 $5,316,804 I/I 1,363,283 9,481,060 1.5 -
BCRX Biocryst Pharmaceuticals ... Indirect Beneficial Owner   –       –       •   2003-10-27 4 S $8.00 $5,968,000 I/I (746,000) 1,455,900 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-12-31 4 S $6.20 $7,359,400 I/I (1,187,000) 1,684,351 -
GYRE Gyre Therapeutics Indirect Beneficial Owner   –       –       •   2009-10-16 4 S $23.60 $15,063,112 D/D (638,400) 2,061,925 0 -
SGXP Sgx Pharmaceuticals, Inc. Indirect Beneficial Owner   –       –       •   2008-08-20 4 D $3.00 $16,523,022 I/I (5,507,674) 0 0 -
ARNA Arena Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2003-10-17 4 S $7.69 $22,385,590 I/I (2,911,000) 2,259,351 -
  195  Records found
  1   2   3   4   5   6   7   8     
  Page 8 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us